Gastroprotección y tratamiento con ácido acetilsalicílico a dosis bajas
Agustí-Escasany, Antònia; Vallano-Ferraz, Antonio.
Med. clín (Ed. impr.)
; 126(6): 232-233, feb. 2006.
Artículo en Es | IBECS (España) | ID: ibc-042610
Documentos relacionados
Aspirin and cancer treatment: systematic reviews and meta-analyses of evidence: for and against.
Daily aspirin for primary prevention increased risk for major GI bleeding in healthy older adults.
Effect of low-dose aspirin on health outcomes: An umbrella review of systematic reviews and meta-analyses.
Safety and Complications of Long-Term Proton Pump Inhibitor Therapy: Getting Closer to the Truth.
Aspirin deprescribing in primary prevention of cardiovascular disease: a prospective risk-benefit approach.
The effect of aspirin in patients with nonvaricose upper gastrointestinal bleeding and risk factors analysis.
Hospitalisation and associated costs of gastrointestinal bleeding from primary prevention aspirin use in South Australia: a retrospective case series analysis.
Pantoprazole and Vonoprazan Performed Well in Preventing Peptic Ulcer Recurrence in Low-Dose Aspirin Users.
Aspirin for the prevention of hepatocellular carcinoma: an updated meta-analysis with particular focus on patients with chronic liver disease.
Reduced risk of gastrointestinal bleeding associated with eupatilin in aspirin plus acid suppressant users: nationwide population-based study.